RxDoctor Payments Data

Ginger Collins, NP

Nurse Practitioner · Big Stone Gap, VANPI 1205497211

Payments from drug & device makers

$1,340in general payments, 2019–2025

Across 87 payments — averaging $15.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$400
  • Gilead$319
  • Indivior Inc.$216
  • Braeburn Inc.$194
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$120
  • Axsome Therapeutics, Inc.$73
  • plus $18 from 1 others

What the payments were for

  • Food & beverage$1,340100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,340 in reported general payments places this provider in the 85th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$33,588
Medicare patients
37
Services billed
235

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl837$62,714
SuboxoneBuprenorphine Hcl/Naloxone Hcl50$15,718
ZubsolvBuprenorphine Hcl/Naloxone Hcl27$14,070
Albuterol Sulfate HfaAlbuterol Sulfate34$863
Ondansetron OdtOndansetron32$839
Naloxone Hcl12$721
Ibuprofen51$461
Quetiapine Fumarate36$333
Quetiapine Fumarate ErQuetiapine Fumarate11$281
Hydroxyzine Pamoate22$252
Omeprazole16$197
Pantoprazole Sodium18$189
Duloxetine Hcl20$166
Ropinirole Hcl16$156
Buspirone Hcl14$95

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Indivior Inc.Suboxone$216$15,71850 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in Big Stone Gap

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →